
Anil Sood
Bio- Pharmaceutical executive with more than 30 years of experience in large scale production and control of vaccines,... | India
*50 free lookup(s) per month.
No credit card required.
Anil Sood’s Emails as****@ja****.com
Anil Sood’s Phone Numbers 1609730****
Social Media
Anil Sood’s Location India
Anil Sood’s Expertise Bio- Pharmaceutical executive with more than 30 years of experience in large scale production and control of vaccines, biologics and sterile injectables with expertise in CMC, Technology Transfer and Quality. Highly proficient in handling large teams with multi-location site activities. In depth knowledge of and ability to apply cGMP, USFDA, MHRA, ANVISA, ICH and WHO-prequalification regulations and guidelines. Extensive experience in working with public health organizations and International not-for profit organizations for various activities related to product development, technology transfers, scale-ups and quality control. Ability to deal and resolve the technical issues for end-to-end delivery of the product and life cycle management of the products.
Anil Sood’s Current Industry The Janssen Pharmaceutical Companies Of Johnson And Johnson
Anil
Sood’s Prior Industry
Janssen
|
Central Drug Laboratory Kasauli
|
Panacea Biotec
|
Baxter International
|
Hilleman Laboratories
|
Path
|
Virchow Biotech
|
The Janssen Pharmaceutical Companies Of Johnson And Johnson
Not the Anil Sood you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

The Janssen Pharmaceutical Companies Of Johnson And Johnson
Expert Vaccine Pharmaceutical & Analytical Development A
Sun Aug 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Virchow Biotech
Site Head Cmc, Quality, Technology Transfer Vaccines (Contractual)
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat May 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Path
Program Director Vaccine Cmc, Technology Transfer And Quality
Mon Jul 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Oct 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Hilleman Laboratories
Sr. Vice President Commercial Vaccine Manufacturing And Quality
Fri Apr 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jul 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Baxter International
Vice President Corporate Quality Assurance
Mon Jun 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Apr 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Panacea Biotec
Site Head
Fri Aug 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jun 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Panacea Biotec
Site Quality Head
Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Panacea Biotec
Sr. General Manager Quality Control & Animal House Operations
Mon Aug 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Apr 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Panacea Biotec
General Manager Fill Finish
Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Jul 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Panacea Biotec
General Manager Quality Control
Fri Feb 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Jan 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Panacea Biotec
Chief Of Quality Control
Sat Apr 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Panacea Biotec
Principal Scientist Quality Control
Fri Apr 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Mar 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Panacea Biotec
Senior Scientist
Sun Apr 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Central Drug Laboratory Kasauli
Technical Officer
Fri Apr 01 1988 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Mar 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Janssen
Expert Vaccine Pharmaceutical and Analytical Development A
— Present